High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients

被引:52
|
作者
Shafer, RW
Hertogs, K
Zolopa, AR
Warford, A
Bloor, S
Betts, BJ
Merigan, TC
Harrigan, R
Larder, BA
机构
[1] Stanford Univ, Med Ctr, Div Infect Dis, Stanford, CA 94305 USA
[2] Stanford Univ, Med Ctr, AIDS Res Ctr, Stanford, CA 94305 USA
[3] Stanford Univ Hosp, Diagnost Virol Lab, Stanford, CA 94305 USA
[4] Stanford Univ Hosp, Dept Biostat, Stanford, CA 94305 USA
[5] VIRCO Belgium, Cent Virol Lab, Mechelen, Belgium
[6] VIRCO UK, Cambridge CB4 4GH, England
关键词
D O I
10.1128/JCM.39.4.1522-1529.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We assessed the reproducibility of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) and protease sequencing using cryopreserved plasma aliquots obtained from 36 heavily treated HIV-1-infected individuals in two laboratories using: dideoxynucleotide sequencing. The rates of complete sequence concordance between the two laboratories were 99.1% for the protease sequence and 99.0% for the RT sequence. Approximately 90% of the discordances were partial, defined as one laboratory detecting a mixture and the second laboratory detecting only one of the mixture's components. Only 0.1% of the nucleotides were completely discordant between the two laboratories, and these were significantly more likely to occur in plasma samples with lower plasma HIV-I RNA levels, Nucleotide mixtures were detected at approximately 1% of the nucleotide positions, and in every case in which one laboratory detected a mixture, the second laboratory either detected the same mixture or detected one of the mixture's components. The high rate of concordance in detecting mixtures and the fact that most discordances between the two laboratories were partial suggest that most discordances were caused by variation in sampling of the HIV-1 quasispecies by PCR rather than by technical errors in the sequencing process itself.
引用
收藏
页码:1522 / 1529
页数:8
相关论文
共 50 条
  • [31] Quantitation of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activity
    Lerma, JGG
    Soriano, V
    Mas, A
    Quiñones-Mateu, ME
    Arts, EJ
    Heneine, W
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (01) : 402 - 405
  • [32] Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particles
    Liao, Wei-Hao
    Huang, Kuo-Jung
    Chang, Yu-Fen
    Wang, Shiu-Mei
    Tseng, Ying-Tzu
    Chiang, Chien-Cheng
    Wang, Jaang-Jiun
    Wang, Chin-Tien
    JOURNAL OF VIROLOGY, 2007, 81 (10) : 5155 - 5165
  • [33] Ribonucleoside Triphosphates as Substrate of Human Immunodeficiency Virus Type 1 Reverse Transcriptase in Human Macrophages
    Kennedy, Edward M.
    Gavegnano, Christina
    Nguyen, Laura
    Slater, Rebecca
    Lucas, Amanda
    Fromentin, Emilie
    Schinazi, Raymond F.
    Kim, Baek
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (50) : 39380 - 39391
  • [34] Recombinant human antibodies against the reverse transcriptase of human immunodeficiency virus type-1
    Herschhorn, A
    Admon, A
    Hizi, A
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2003, 1648 (1-2): : 154 - 163
  • [35] THE STRUCTURE OF UNLIGANDED REVERSE-TRANSCRIPTASE FROM THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    RODGERS, DW
    GAMBLIN, SJ
    HARRIS, BA
    RAY, S
    CULP, JS
    HELLMIG, B
    WOOLF, DJ
    DEBOUCK, C
    HARRISON, SC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (04) : 1222 - 1226
  • [36] Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals
    Brindeiro, R
    Vanderborght, B
    Caride, E
    Correa, L
    Oravec, RM
    Berro, O
    Stuyver, L
    Tanuri, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) : 1674 - 1680
  • [37] Modulation of human immunodeficiency virus type 1 synergistic inhibition by reverse transcriptase mutations
    Basavapathruni, Aravind
    Vingerhoets, Johan
    de Bethune, Marie-Pierre
    Chung, Raymond
    Bailey, Christopher M.
    Kim, Jiae
    Anderson, Karen S.
    BIOCHEMISTRY, 2006, 45 (23) : 7334 - 7340
  • [38] Properties of human immunodeficiency virus type 1 reverse transcriptase recombination upon infection
    Sakuragi, Sayuri
    Shioda, Tatsuo
    Sakuragi, Jun-ichi
    JOURNAL OF GENERAL VIROLOGY, 2015, 96 : 3382 - 3388
  • [39] Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine
    Lennerstrand, J
    Stammers, DK
    Larder, BA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) : 2144 - 2146
  • [40] Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitor
    Pilon, AA
    Lum, JJ
    Sanchez-Dardon, J
    Phenix, BN
    Douglas, R
    Badley, AD
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) : 2687 - 2691